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Background: The chemiluminescence (CL) and immunofluorescence (IF) assays yield different results for basal 
adrenocorticotropin hormone concentrations [ACTH] in pony plasma. It is unclear whether this difference also 
occurs in basal samples from horses or samples from ponies following thyrotropin-releasing hormone (TRH) 
stimulation. 
Objectives: To compare the results of [ACTH] analysis by CL and IF methods in basal samples from horses and pony 
samples following TRH stimulation. 
Study design: Method comparison. 
 
Methods: Plasma [ACTH] was measured concurrently using CL and IF methods in 12 ponies (basal and post TRH 
stimulation) in November and basal samples from horses (n = 45; November and May). 
Results: CL and IF methods yielded different results (P<0.01). The median difference (CL – IF) (95%CI) for ponies was 
5.9 (0.1-7.5)pg/ml at baseline and 227.9 (61-1001)pg/ml post TRH; and horses 1.9 (1.1-5.4)pg/ml in November and 
9.4 (8.2-11.5)pg/ml in May, at baseline. Correlation was good in ponies at baseline (R=0.80, p=0.003) but not post 
TRH, and good in horses in November and May (R=0.68 and 0.71, p<0.001). Bland-Altman analysis demonstrated 
moderate bias and wide 95% limits of agreement (95%LOA) in ponies at baseline (bias 5.5pg/ml; 95%LOA -9.9- 
20.9pg/ml) and horses in May (bias 10.6pg/ml; 95%LOA -9-30.3pg/ml) and very large bias and wide 95%LOA in 
ponies post TRH (bias 477pg/ml; 95%LOA -633-1587pg/ml). Using CL cut-offs of >29pg/ml and >110pg/ml, 
agreement was moderate (ƙ=0.67) and very good (ƙ=0.82) for binary classification of PPID in ponies at baseline and 
post TRH; and good (ƙ=0.73) for horses in November, but poor (ƙ=0.40) in May. 
Main limitations: Limited numbers of horses with [ACTH] above threshold values. 
 
Conclusions: The assays yielded different absolute values, particularly in post TRH samples from ponies, suggesting 
TRH stimulates secretion of cross-reacting peptides other than ACTH. Agreement for binary classification for PPID 






Analysis of plasma adrenocorticotropin hormone concentration [ACTH], both at baseline and following thyrotropin- 
releasing hormone (TRH) stimulation, is used to aid the diagnosis of equine pituitary pars intermedia dysfunction 
(PPID) [1]. The TRH stimulation test can be used to assist diagnosis of PPID where baseline [ACTH] is equivocal or 
negative and PPID is suspected. Plasma [ACTH] can vary in individuals and TRH stimulation tests are thought to 
reduce the relative impact of confounding factors by maximally and specifically stimulating the pars intermedia of 
the pituitary gland [2]. Two methods for measurement of [ACTH] in the horse, namely the chemiluminescent (CL) 
and immunofluorescent (IF) assays, have demonstrated acceptable precision and accuracy [3]. Seasonally adjusted 
CL reference ranges for baseline [ACTH] are widely used, and more recently seasonally adjusted post TRH 
stimulation [ACTH] cut-offs have been reported [4,5]. The post TRH stimulation test [ACTH] cut-off values are an 
ongoing area of research, with current cut-offs indicating a wide range of equivocal values [6]. 
 
 
It was previously demonstrated that the CL and IF methods yielded significantly different results when [ACTH] was 
measured in EDTA plasma samples collected from ponies in spring and autumn. In addition, the association between 
these CL and IF results were shown to differ in autumn and spring, consistent with seasonally dependent assay cross- 
reactivity or interference [7]. Corticotropin-like intermediate lobe peptide (CLIP) was considered to be the most   
likely in vivo cross reactant [7]. Previous studies have demonstrated endocrine differences between horses and 
ponies including differences in concentrations of α-MSH, ACTH and insulin [8,9]. Thus, it is possible that pituitary- 
derived cross reactants may have different effects with respect to the measurement of [ACTH] using these two  
assays in plasma samples collected from horses rather than ponies. In addition, the possibility of pituitary-derived 
cross-reactants affecting the measurement of [ACTH] in samples collected from ponies following TRH stimulation has 
yet to be determined. Thus, the aim of the current study was to compare [ACTH] as determined by the CL and IF 







Twelve university kept ponies and 90 clinically healthy, mature adult, non-Thoroughbred horses, kept as a single 
group with one owner, were included in the study. The ponies were all British native breed mares and <148cm in 
height at the withers with a mean age of 17.42 (range: 9 – 25) years. Seven of the ponies had a history of previous 
laminitis and two had hypertrichosis. All ponies underwent TRH stimulation tests on the same day in late November 
following a previous equivocal baseline [ACTH]. The horses were all ≥148cm in height and 67 were geldings and 23 
were mares. None of the horses had any clinical signs consistent with PPID. Residual plasma was obtained following 
blood sampling for tapeworm infection monitoring on one of two dates in November (n=45) and in May (n=45). All 
animals were clinically healthy at the time of sampling and none were pregnant or lactating. 
In the ponies, a baseline blood sample was obtained from the jugular vein into plastic EDTA vacutainersa. This was 
followed by intravenous injection of 1 mg TRHb. A second EDTA blood sample was collected after 10 minutes. 
Horses’ residual blood was put into plastic EDTA vacutainersa following sampling from the jugular vein. All whole 
blood samples were immediately chilled on ice, separated by centrifuge (10 min at 2000x g) within 6 hours and the 
plasma aliquoted and frozen at -80°C on the same day until analysis. Samples were thawed and analysed on the 
same day. Concurrent analysis of each sample was performed on two automated analysers: a solid phase 2-site 
sequential chemiluminescent immunometric assay using mouse monoclonal and rabbit polyclonal anti-human ACTH 
antibodies (ACTH Immulite 1000c) and a 2-site immunoenzymometric assay using 2 types of polyclonal goat anti- 






Animals with ACTH concentrations above the reference interval, according to published seasonally adjusted [ACTH] 
cut-offs [4,6], were reported as percentages for each sample group. The median and interquartile ranges (IQRs) were 
calculated for the results of each method among ponies at baseline and following TRH stimulation and among horses 
at baseline in November and May. The distributions of the differences between paired ACTH values (CL – IF) were 
analysed for normality using histograms and Shapiro-Wilk normality tests. To determine whether there was a 
difference between the results obtained from the CL and IF assays the [ACTH] of the concurrently analysed samples 
were compared using Wilcoxon matched-pairs signed rank tests. The relationships between the CL and IF [ACTH] 
were examined using scatter plots, Spearman correlation and linear regression. The residuals of linear regression 
were normally distributed. The slopes of the linear regression curves compared using a F tests. Absolute difference 
Bland-Altman (Bland-Altman) plots were used to examine the bias and 95% limits of agreement (LOA) between the 
methods among ponies at baseline and following TRH stimulation and among horses at baseline in November and 
May. 
Samples with CL [ACTH] > 29pg/ml at baseline and >110pg/ml following TRH stimulation were classified as positive 
for PPID and samples with [ACTH] below these values were classified as negative [4,6]. ROC analysis and the 
maximum Youden index method were used to determine corresponding IF cut-offs to the CL cut-offs. Kappa analysis 
was used to determine agreement between the assays for binary classification. Kappa values of >0.81 were 
considered to indicate very good agreement, 0.61-0.8 good, 0.41-0.6 moderate, 0.21-0.4 fair and <0.2 as poor [10]. 




Two samples from horses in November yielded CL [ACTH] below the lower limit of detection and were thus excluded 
from further analysis. The number of ponies with ACTH concentrations above the reference values was 4/12 using 
baseline values and 8/12 using values following TRH stimulation; all 4 ponies with ACTH concentrations above the 
reference values at baseline also had results above the reference value following TRH stimulation. Two ponies with 
previous laminitis and one with hypertrichosis had ACTH concentrations above the reference values at baseline. 
Both ponies with hypertrichosis and 5 ponies with previous laminitis had ACTH concentrations above the reference 
value following TRH stimulation. In horses, 12% (5/43) had ACTH concentrations above the reference value in 
November and 22% (10/45) in May. 
The median (IQR) [ACTH] (pg/ml) values measured using the CL and IF assays were 20.2 (29) and 19.2 (26.8) in ponies 
at baseline (Fig 1); and 274 (851.3) and 43.7 (63.3) in ponies following TRH stimulation (Fig 2), respectively. In horses, 
this was 17.5 (4.5) and 15.7 (7.6) in November and 24.6 (8.3) and 13.4 (8.4) in May (Fig 3). 
 
The median difference between assay results (CL – IF) (95%CI) were 5.9 (0.1-7.5) pg/ml (p=0.01) at baseline and 
227.9 (61-1001) pg/ml post TRH (p<0.001) in ponies; in horses they were 1.9 (1.1-5.4) pg/ml in November (p=0.003) 
and 9.4 (8.2-11.5) pg/ml in May (p<0.001). 
Spearman correlation between assays in ponies was good at baseline (R = 0.80, p=0.003) but weak post TRH (R = 
0.57, p=0.06). Among horses, Spearman correlation was good (R = 0.68 and 0.71, P<0.001) in November and May, 
respectively. 
Linear regression demonstrated IF = 0.68 X CL + 3.94 (R2 = 0.90) in ponies at baseline (Fig 4), IF = 0.62 X CL + 4.41 (R2 
= 0.47) in horses in November and IF = 0.53 X CL + 1.8 (R2 = 0.46) in horses in May (Fig 5). There was no evidence for 
a significant difference (F=0.27; p=0.6) when comparing the linear regression slopes of the horses in November and 
May. 
Bland-Altman analysis (Fig 6) demonstrated mean bias and 95% limits of agreement (95% LOA) of 5.52pg/ml (-9.91 - 
20.94pg/ml) in ponies at baseline and 477pg/ml (-633.20 - 1587pg/ml) in ponies following TRH stimulation. In horses 
they were 10.61pg/ml (-9.04 - 30.25pg/ml) in May and 0.037 pg/ml (-38.49 – 38.56pg/ml) in November. 
Receiver operating characteristic (ROC) and Youden index calculations, using a CL non-autumn cut-off of 29pg/ml 
and post TRH cut-off of 110pg/ml, demonstrated the greatest agreement between IF and CL assays for binary 
classification when a diagnostic cut-off of >22.90pg/ml was used for the IF assay for baseline ACTH concentrations in 
November and >15.2pg/ml in May for horses, and >19.2pg/ml for baseline ACTH concentrations and > 32.2pg/ml for 
ACTH concentrations following TRH stimulation in ponies in November. 
Using the same CL assay cut-offs there was moderate (ƙ=0.67) and very good (ƙ =0.82) agreement for binary 
classification of PPID in ponies at baseline and post TRH. In horse agreement was good (ƙ =0.73) in November, but 
poor (ƙ =0.40) in May. 
Discussion 
 
The assay used to measure ACTH concentration is important for the clinical interpretation of the results. Poor 
agreement between equine [ACTH] values measured using CL methods and a commercial radioimmunoassay has 
been reported previously [11]. The findings of this study agree with those of Irvine et al. [3] and Knowles et al. [7], 
demonstrating that the [ACTH] is also significantly lower when measured using IF compared to CL methods in 
concurrently run samples obtained from horses or ponies at baseline or ponies post TRH stimulation test. 
The differences between the assay results in this study were large enough to affect clinical interpretation and 
highlights the requirement for assay specific thresholds. The correlation of [ACTH] measured in ponies using the two 
assays was good at baseline, however the median of differences, the Bland-Altman bias and 95% limits of agreement 
(LOA) were deemed large and wide enough to impact clinical interpretation of results. The post TRH stimulation test 
results were not significantly correlated, the median of differences was very large and Bland-Altman analysis 
 
demonstrated very large bias and wide 95% LOA. Together, these findings indicate that the absolute test results   
were not comparable at baseline nor following TRH stimulation in ponies. However, due to the small sample size, the 
wide LOA and the magnitude of the differences between assays in this group, this should be interpreted with caution.  
There was a statistically significant difference in results using samples from horses obtained at baseline in both 
November and May. The differences seen in November were very small and unlikely to affect clinical      
interpretation using CL diagnostic thresholds, with low Bland-Altman bias and the wider 95% LOA likely influenced   
by a single outlier. In May, the median of differences was deemed large enough to affect interpretation and the 
Bland-Altman bias and 95% LOA were also large. Thus, overall the tests were comparable in November but not May. 
Knowles et al. [7] identified a different relationship between [ACTH] generated by the two methods when comparing 
samples collected from the same ponies in the autumn and the spring. In the present study the association between 
the [ACTH] results in horses did not differ significantly with time of year, however both sampling times in the current 




The most notable finding of the current study is the large difference in [ACTH] between the two assays following TRH 
stimulation. TRH receptors on the melanotrophs of the pars intermedia are stimulated by exogenous TRH, leading to 
secretion of α-MSH, CLIP, and β-endorphin, with hyperplastic or neoplastic melanotrophs also secreting significant 
amounts of ACTH [12]. Our finding in ponies of very large differences in [ACTH] following TRH stimulation supports 
the theory set out by Knowles et al. [7] of probable cross-reactivity or interference by another substance in the CL 
assay, resulting in the large differences in [ACTH] between the two methods. Given the reported cross reactivity of 
the CL assay to synthetic CLIP in equine plasma [7], CLIP would be a likely candidate peptide for the effect seen in the 
present study following TRH stimulation. The cross reactivity likely occurs due to the antibody targets. For the IF 
assay, the targets are ACTH 1-16 and 24-39 and so the assay will only detect the intact ACTH peptide. Whereas, the 
primary antibody in the CL assay is directed to CLIP (ACTH 18-39) and the secondary is a polyclonal for ACTH 1-24, so 
if CLIP is bound to the primary antibody then the N-terminal 7 amino acids of CLIP (ACTH 18-24) can act as an epitope 
for the CL secondary antibody. ACTH 18-24 is conserved perfectly between horse [13] and human [14] and                 
so the IF assay is therefore likely to be more specific for ACTH. Given the magnitude of the differences between the 
assay results and degree of reported cross reactivity, it appears that ACTH is a relatively minor product of the pars 
intermedia in some ponies when compared with the cross reacting POMC(s). Prohormone convertase 2 cleaves ACTH 
into alpha MSH and CLIP and would be expected to produce equimolar amounts of each, although CLIP may   
undergo further cleavage [15]. As sampling occurred in late November, consideration must be given to the possibility 
of late autumnal seasonal effects on the pituitary secretome at this time of year [14]. 
A non-autumnal [ACTH] cut-off of 29pg/ml [4]and post TRH stimulation [ACTH] cut-off 110pg/ml [6] were used for 
the classification of samples as above or below the reference values in order to explore binary agreement between 
the assays. The most recent recommendations outline a 3-tier classification of PPID results with negative, equivocal 
and positive ranges [6,16]. This classification was not used in the current study due to low numbers falling within the 
 
equivocal ranges and the aim of this study being to compare the assay results, rather than validate or define cut-offs 
for an assay. These results must therefore be interpreted with caution due to low numbers, particularly among the 
ponies, and the lack of inclusion of horses with clinical signs consistent with PPID. In addition, these IF cut-off values 
should not be extrapolated to other populations. The agreement for binary interpretation of the results using the 
above cut-off values were moderate and very good among ponies pre and post TRH stimulation, and good and poor 
for horses in November and May, respectively. The poor agreement among horses in May could be explained by a 




In conclusion the assays yielded different absolute values, particularly in samples from ponies’ post TRH stimulation, 
suggesting TRH stimulates secretion of cross-reacting peptides other than ACTH. The CL and IF assays cannot be used 
interchangeably, particularly following TRH stimulation for diagnosis of PPID, and assay specific thresholds are vital. 
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Fig 1: Box and whisker plots of [ACTH] measured with the CL and IF assays in ponies at baseline. Whiskers 
demonstrate the maximum and minimum values; box borders the first and third quartiles and the horizontal 
line within each box the median. *p=0.01 
 
Fig 2: Box and whisker plots of [ACTH] measured with the CL and IF assays in ponies following TRH stimulation. 
Whiskers demonstrate the maximum and minimum values; box borders the first and third quartiles and the 




Fig 3: Box and whisker plots of [ACTH] measured with the CL and IF assays in horses at baseline in 
November and May. Whiskers demonstrate the maximum and minimum values; box borders the first and 
third quartiles and the horizontal line within each box the median. *p=0.003, **p<0.001 
 
Fig 4: Scatter plots of [ACTH] measured using the CL and IF assays in ponies at baseline with linear regression 




Fig 5: Scatter plots of [ACTH] measured using the CL and IF assays in horses in November and May with linear 
regression lines fitted. November: IF = 0.62 X CL + 4.41 (R2 = 0.47), May: IF = 0.53 X CL + 1.8 (R2 = 0.46) 
 
 
Fig 6: Absolute difference Bland-Altman plots (CL - IF) showing differences between results in: A. ponies at 
baseline; B. ponies post TRH stimulation; C. horses in May; and D. horses in November. Solid lines represent 
mean differences and dotted lines the LOA. The mean difference for figure D is 0.04 with the solid line not 
represented on the chart. 
 
 
